Skip to content
★ Sign in to follow
RJ

Richard Jones

Mereo BioPharma Group plc
Total declarations
4
Company
1
▲ Purchases (2 ops.)
€16k
▼ Sales (0 ops.)
—

Latest filing published 24 Jul 2019 for Mereo BioPharma Group plc.

Filing timeline

BuySale
Richard Jones

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2
Positive at T+90
0%
Median T+90
-46.6%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Richard Jones: trading record in brief

Richard Jones is a declared insider of Mereo BioPharma Group plc, with filings sourced from SEC (Form 4). Between 29 April 2019 and 24 July 2019, the trades on record add up to 4 filings.

Purchases make up the whole of the open-market record (2 purchases, €16k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 2 share grants.

The latest filing, published on 24 July 2019, reports a share grant in Mereo BioPharma Group plc. The most recent open-market purchase was published on 1 May 2019, 2,749 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Richard Jones

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ◆
    Chief Financial OfficerExecutivesMereo BioPharma Group plc
    0FCA-NSM
    27,500 sharesOutside of a trading venueFCA-NSM:LSE20190724100812_14161287_20200326185123408_10441-2
  • ◆
    Chief Financial OfficerExecutivesMereo BioPharma Group plc
    0FCA-NSM
    27,500 sharesOutside of a trading venueFCA-NSM:LSE20190521150839_14082298_20200326185142080_11482-2
  • ▲
    Chief Financial OfficerExecutivesMereo BioPharma Group plc
    6,237 USD40FCA-NSM
    1,050 shares@ US$5.9433.7% of flowXNMSFCA-NSM:LSE20190501154759_14059895_20200326185143203_28677-2
    Canonical exit: 29 Jul 2019 (T+90)
  • ▲
    Chief Financial OfficerExecutivesMereo BioPharma Group plc
    12,231 USD38FCA-NSM
    2,025 shares@ US$6.0466.3% of flowXNMSFCA-NSM:LSE20190430151521_14057802_20200326185040087_294-1
    Canonical exit: 28 Jul 2019 (T+90)

4 of 4 declarations